Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
New Toothpaste Containing SnF is an experimental oral care formulation developed by Colgate-Palmolive containing stannous fluoride (SnF2) as the active ingredient. Stannous fluoride is a well-established anticavity, antigingivitis, and desensitizing agent. It works by delivering fluoride ions that bind to hydroxyapatite in tooth enamel, promoting remineralization and forming fluorapatite, which is highly resistant to acid dissolution and enamel erosion. Additionally, the stannous ions provide antibacterial activity by disrupting bacterial cell membranes, inhibiting metabolic enzymes (such as those involved in glycolysis), and reducing plaque biofilm viability. Colgate-Palmolive has evaluated this formulation in Phase 3 clinical trials for the prevention of enamel erosion, as well as for controlling dental plaque and gingivitis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on New Toothpaste Containing SnF.